120 related articles for article (PubMed ID: 16962683)
1. Hypothalamic clamp on insulin release by leptin-transgene expression.
Boghossian S; Dube MG; Torto R; Kalra PS; Kalra SP
Peptides; 2006 Dec; 27(12):3245-54. PubMed ID: 16962683
[TBL] [Abstract][Full Text] [Related]
2. Leptin transgene expression in the hypothalamus enforces euglycemia in diabetic, insulin-deficient nonobese Akita mice and leptin-deficient obese ob/ob mice.
Ueno N; Inui A; Kalra PS; Kalra SP
Peptides; 2006 Sep; 27(9):2332-42. PubMed ID: 16621153
[TBL] [Abstract][Full Text] [Related]
3. Central leptin gene therapy blocks high-fat diet-induced weight gain, hyperleptinemia, and hyperinsulinemia: increase in serum ghrelin levels.
Dube MG; Beretta E; Dhillon H; Ueno N; Kalra PS; Kalra SP
Diabetes; 2002 Jun; 51(6):1729-36. PubMed ID: 12031959
[TBL] [Abstract][Full Text] [Related]
4. Leptin modulates orexigenic effects of ghrelin and attenuates adiponectin and insulin levels and selectively the dark-phase feeding as revealed by central leptin gene therapy.
Ueno N; Dube MG; Inui A; Kalra PS; Kalra SP
Endocrinology; 2004 Sep; 145(9):4176-84. PubMed ID: 15155574
[TBL] [Abstract][Full Text] [Related]
5. High-fat diet induces leptin resistance in leptin-deficient mice.
Koch CE; Lowe C; Pretz D; Steger J; Williams LM; Tups A
J Neuroendocrinol; 2014 Feb; 26(2):58-67. PubMed ID: 24382295
[TBL] [Abstract][Full Text] [Related]
6. Central leptin gene therapy suppresses body weight gain, adiposity and serum insulin without affecting food consumption in normal rats: a long-term study.
Dhillon H; Kalra SP; Prima V; Zolotukhin S; Scarpace PJ; Moldawer LL; Muzyczka N; Kalra PS
Regul Pept; 2001 Jun; 99(2-3):69-77. PubMed ID: 11384767
[TBL] [Abstract][Full Text] [Related]
7. Leptin increases osteoblast-specific osteocalcin release through a hypothalamic relay.
Kalra SP; Dube MG; Iwaniec UT
Peptides; 2009 May; 30(5):967-73. PubMed ID: 19428775
[TBL] [Abstract][Full Text] [Related]
8. Hypothalamic leptin gene therapy prevents weight gain without long-term detrimental effects on bone in growing and skeletally mature female rats.
Iwaniec UT; Boghossian S; Trevisiol CH; Wronski TJ; Turner RT; Kalra SP
J Bone Miner Res; 2011 Jul; 26(7):1506-16. PubMed ID: 21328617
[TBL] [Abstract][Full Text] [Related]
9. Hypothalamic Leptin Gene Therapy Reduces Bone Marrow Adiposity in ob/ob Mice Fed Regular and High-Fat Diets.
Lindenmaier LB; Philbrick KA; Branscum AJ; Kalra SP; Turner RT; Iwaniec UT
Front Endocrinol (Lausanne); 2016; 7():110. PubMed ID: 27579023
[TBL] [Abstract][Full Text] [Related]
10. Leptin expression in hypothalamic PVN reverses dietary obesity and hyperinsulinemia but stimulates ghrelin.
Bagnasco M; Dube MG; Katz A; Kalra PS; Kalra SP
Obes Res; 2003 Dec; 11(12):1463-70. PubMed ID: 14694210
[TBL] [Abstract][Full Text] [Related]
11. Increased leptin expression selectively in the hypothalamus suppresses inflammatory markers CRP and IL-6 in leptin-deficient diabetic obese mice.
Dube MG; Torto R; Kalra SP
Peptides; 2008 Apr; 29(4):593-8. PubMed ID: 18325632
[TBL] [Abstract][Full Text] [Related]
12. Long-term effects of central leptin and resistin on body weight, insulin resistance, and beta-cell function and mass by the modulation of hypothalamic leptin and insulin signaling.
Park S; Hong SM; Sung SR; Jung HK
Endocrinology; 2008 Feb; 149(2):445-54. PubMed ID: 17991727
[TBL] [Abstract][Full Text] [Related]
13. Leptin gene transfer in the hypothalamus enhances longevity in adult monogenic mutant mice in the absence of circulating leptin.
Boghossian S; Ueno N; Dube MG; Kalra P; Kalra S
Neurobiol Aging; 2007 Oct; 28(10):1594-604. PubMed ID: 17011078
[TBL] [Abstract][Full Text] [Related]
14. Central leptin gene therapy corrects skeletal abnormalities in leptin-deficient ob/ob mice.
Iwaniec UT; Boghossian S; Lapke PD; Turner RT; Kalra SP
Peptides; 2007 May; 28(5):1012-9. PubMed ID: 17346852
[TBL] [Abstract][Full Text] [Related]
15. Pivotal role of leptin-hypothalamus signaling in the etiology of diabetes uncovered by gene therapy: a new therapeutic intervention?
Kalra SP
Gene Ther; 2011 Apr; 18(4):319-25. PubMed ID: 21209624
[TBL] [Abstract][Full Text] [Related]
16. Suppressing hyperinsulinemia prevents obesity but causes rapid onset of diabetes in leptin-deficient
D'souza AM; Johnson JD; Clee SM; Kieffer TJ
Mol Metab; 2016 Nov; 5(11):1103-1112. PubMed ID: 27818936
[TBL] [Abstract][Full Text] [Related]
17. Perigestational suppression of weight gain with central leptin gene therapy results in lower weight F1 generation.
Lecklin A; Dube MG; Torto RN; Kalra PS; Kalra SP
Peptides; 2005 Jul; 26(7):1176-87. PubMed ID: 15949636
[TBL] [Abstract][Full Text] [Related]
18. Chronic central leptin decreases food intake and improves glucose tolerance in diet-induced obese mice independent of hypothalamic malonyl CoA levels and skeletal muscle insulin sensitivity.
Keung W; Palaniyappan A; Lopaschuk GD
Endocrinology; 2011 Nov; 152(11):4127-37. PubMed ID: 21914780
[TBL] [Abstract][Full Text] [Related]
19. Central leptin gene therapy, a substitute for insulin therapy to ameliorate hyperglycemia and hyperphagia, and promote survival in insulin-deficient diabetic mice.
Kojima S; Asakawa A; Amitani H; Sakoguchi T; Ueno N; Inui A; Kalra SP
Peptides; 2009 May; 30(5):962-6. PubMed ID: 19428774
[TBL] [Abstract][Full Text] [Related]
20. Evidence that diet-induced hyperleptinemia, but not hypothalamic gliosis, causes ghrelin resistance in NPY/AgRP neurons of male mice.
Briggs DI; Lockie SH; Benzler J; Wu Q; Stark R; Reichenbach A; Hoy AJ; Lemus MB; Coleman HA; Parkington HC; Tups A; Andrews ZB
Endocrinology; 2014 Jul; 155(7):2411-22. PubMed ID: 24742194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
